Analysts expect Phathom Pharmaceuticals, Inc. to report revenue of 82.25 M for Q3 26, against a range of 74.52 M to 89.99 M. The most recent reported quarter, Q2 26, came in at 74.27 M, a 2.9% miss against the 76.50 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 16.35 M | 29.66 M | 28.52 M | 39.50 M | 49.50 M | 57.58 M | 58.30 M | 74.27 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 14.15 M | 24.13 M | 28.67 M | 36.90 M | 53.57 M | 55.33 M | 58.66 M | 81.31 M | 89.99 M | 107.07 M | 108.81 M | 129.31 M | 131.43 M | 143.92 M | 154.08 M | 174.22 M | ||||||||||
| Low Estimate | 12.79 M | 22.28 M | 26.69 M | 31.89 M | 45.93 M | 51.96 M | 50.53 M | 71.70 M | 74.52 M | 99.17 M | 89.61 M | 109.78 M | 108.27 M | 121.81 M | 132.03 M | 148.53 M | ||||||||||
| Consensus Estimate | 13.47 M | 23.21 M | 27.68 M | 34.39 M | 49.75 M | 53.65 M | 54.60 M | 76.50 M | 82.25 M | 103.12 M | 99.21 M | 119.54 M | 119.85 M | 132.86 M | 143.05 M | 161.38 M |
Analysts expect Phathom Pharmaceuticals, Inc. to report earnings per share of -0.10 for Q3 26, against a range of -0.11 to -0.09. The most recent reported quarter, Q2 26, came in at -0.21, a 10.5% miss against the -0.19 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.32 | -1.05 | -1.31 | -1.05 | -0.41 | -0.29 | -0.37 | -0.21 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -1.30 | -1.05 | -0.96 | -0.85 | -0.39 | -0.38 | -0.26 | -0.18 | -0.09 | -0.03 | -0.03 | 0.15 | 0.42 | 0.50 | 0.23 | 0.40 | ||||||||||
| Low Estimate | -1.46 | -1.23 | -1.08 | -0.99 | -0.47 | -0.40 | -0.30 | -0.20 | -0.11 | -0.03 | -0.03 | 0.13 | 0.36 | 0.46 | 0.19 | 0.38 | ||||||||||
| Consensus Estimate | -1.38 | -1.14 | -1.02 | -0.92 | -0.43 | -0.39 | -0.28 | -0.19 | -0.10 | -0.03 | -0.03 | 0.14 | 0.39 | 0.48 | 0.21 | 0.39 |
Pull Wall Street consensus for Phathom Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=PHAT&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "PHAT", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=PHAT&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();